Simmaron’s Solve ME/CFS Catalyst Award-Winning Rapamycin Trial Yields Promising Treatment Findings
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a non-profit organization dedicated to understanding ME/CFS and related diseases and to treating people with these diseases. […]
Targeting Autophagy: A Clinical Trial of Low-Dose Rapamycin for ME/CFS, Long COVID, and IACCIs
Simmaron Research is the second recipient of Solve’s ME/CFS Catalyst Award in support of its study,” “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” Read a preprint […]
Solve Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs
Dr. C. Gunnar Gottschalk and Dr. Avik Roy Solve M.E. is proud to announce that we’ve selected the Simmaron Research Institute as the winner of our second Solve ME/CFS Catalyst […]
Solve M.E. and Simmaron-Funded Research Finds New Animal Models for Studying ME/CFS
Post-exertional malaise (PEM) is the most prominent and common symptom of ME/CFS, but researchers have struggled to fully understand why patients with ME/CFS have this symptom. An important roadblock is […]
Hope Amid Uncertainty
A special message from Solve M.E. President and CEO Emily Taylor With so much speculation about the future, it’s easy to feel unsettled – and uncertainty is especially hard for […]
Tetrahydrobiopterin—A Cause of Orthostatic Imbalance in People with ME/CFS
Dr. Avik Roy is the chief scientific officer and chief of neurobiology at the Simmaron Research Institute, a nonprofit organization researching ways to treat patients with ME/CFS or Long Covid. […]
NIH ME/CFS Telebriefing
NIH’s next ME/CFS Advocacy Call will be held on May 1, 2023 from 12:00 – 1:00 pm ET. The webinar will include updates from NIH on ME/CFS-related research activities and […]